newsfilter
← Latest News
GlobeNewswire·

Aravive Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

HOUSTON, March 15, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV, "the Company")), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today reported fourth